J
Market Data
$20.58+$0.83 (+4.20%)
JBIO · Last trade
Prev Close
$19.75
Range (31d)
$19.15 – $24.71
Recent Filings
- SCHEDULE 13G/A18.6 KBJade Biosciences, Inc.Aug 14, 4:50 PM ET·0001231919-26-000932
- SCHEDULE 13G/A10.1 KBJade Biosciences, Inc.Aug 14, 11:57 AM ET·0001104659-26-096751
- 10-Q13.2 MBJade Biosciences, Inc.Aug 10, 7:21 AM ET·0001193125-26-341242
- 8-K241.1 KBJade Biosciences, Inc.Aug 10, 7:13 AM ET·0001193125-26-341229
- 8-K148.7 KBJade Biosciences, Inc.Jul 1, 4:41 PM ET·0001193125-26-292704
- 8-K169.2 KBJade Biosciences, Inc.Jun 26, 7:15 AM ET·0001193125-26-283906
- 8-K551.9 KBJade Biosciences, Inc.Jun 11, 4:28 PM ET·0001193125-26-267640
- 8-K544.5 KBJade Biosciences, Inc.Jun 4, 5:09 PM ET·0001193125-26-257733
- 8-K3.4 MBJade Biosciences, Inc.Jun 1, 7:55 AM ET·0001193125-26-249763
- 10-Q10.8 MBJade Biosciences, Inc.May 7, 4:27 PM ET·0001193125-26-212088
Insiders
10- Atlas Venture Associates XII, L.P.10% Owner
- Atlas Venture Fund XII, L.P.10% Owner
- Balta ElizabethSee Remarks
- CAIN CHRISTOPHER W.Director
- Chen BihuaFormer 10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
- Cormorant Private Healthcare Fund II, LPFormer 10% Owner
- Dable Habib JDirector
- Dahms Bradford D.Chief Financial Officer
- Dake Benjamin TSEE REMARKS
Tickers
Addresses
business
221 CRESCENT ST. BUILDING 23, SUITE 105
WALTHAM, MA, 02453
mailing
221 CRESCENT ST. BUILDING 23, SUITE 105
WALTHAM, MA, 02453
Former Names
- Aerovate Therapeutics, Inc.2025-04-30